Anatomic Pathology Market is Estimated to Develop at a CAGR of 7.0% during the Forecast Period, notes MnM Study
The growth of this Anatomic Pathology market is mainly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, reimbursement possibilities, and growing interest in personalized medicines.
[343 Pages Report] The anatomic pathology market is
projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a
CAGR of 7.0%.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Report Scope and Market Segmentation:
|
Report Metric |
Details |
|
Market Size Available for Years |
2019–2026 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2022–2026 |
|
Forecast Units |
Value (USD Billion) |
|
Segments Covered |
By product & service, application, end user,
and region. |
|
Geographies Covered |
North America, Europe, APAC, LATAM, and MEA |
|
Companies Covered |
F. Hoffmann-La Roche AG (Switzerland), Danaher
Corporation (US), PHC Holdings Corporation (Japan), Beckton, Dickson and
Company (US), Abcam plc. (UK), Hologic, Inc. (US), Agilent Technologies
(US), Merck KGaA (Germany), Sakura Finetek (US), Bio SB (US), BioGenex (US),
Milestone Medical (Italy), Histo-Line Laboratories (Italy), Diapath S.p.A
(Italy), SLEE medical GmbH (Germany), Amos Scientific Pty Ltd (Australia),
MEDITE Medical GmbH (Germany), Cell Signaling Technology, Inc. (US), CellPath
Ltd. (UK), Jinhua Yidi Medical Equipment Co., Ltd. (China), MICROS AUSTRIA
(Austria), R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED (India), Lupetec
(Brazil), Medimeas (India), and Bright Instruments (UK). |
Anatomic Pathology Services segment accounted for the
largest share of the global anatomic pathology market
Based on product & service, the anatomic pathology
market is segmented into services, consumables, and instruments. The services
segment accounted for the largest market share. The large share of this segment
can be attributed to the availability of reimbursements for diagnostic tests,
rapid growth in the geriatric population, and the increasing incidence of
cancer and other chronic diseases.
By Application, disease diagnostics accounted for the
largest market share
Based on application, the anatomic pathology market is
segmented into disease diagnostics and medical research. The disease
diagnostics segment accounted for a larger share of the market
By End User, Hospital laboratories accounted for the
largest market share
Based on end user, the anatomic pathology market is
segmented into hospital laboratories, clinical laboratories, and other end
users. Hospital laboratories accounted for the largest share
North America dominates the anatomic pathology market
North America accounted for the largest share of the
anatomic pathology market. Factors such as the rising prevalence of chronic
diseases, increasing healthcare expenditure, the high-quality infrastructure
for hospitals and clinical laboratories, and the presence of major market
players in the region are driving the growth of the anatomic pathology market
in North America.
F. Hoffmann-La Roche AG (Switzerland) is the leading
player in the anatomic pathology market in 2020. The company has a wide range
of products in the consumables segment. Strong business operations across all
key regions, coupled with a strong brand image, make the firm a leading player
in this market.
Comments
Post a Comment